缩写名/全名 |
VALUE HEALTH
VALUE IN HEALTH |
||||||||||||||||||||
ISSN号 | 1098-3015 | ||||||||||||||||||||
研究方向 | 医学-卫生保健 | ||||||||||||||||||||
影响因子 | 2015:3.824, 2016:4.235, 2017:5.494, 2018:5.037, 2019:4.748, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||||||
年文章数 | 175 | ||||||||||||||||||||
出版年份 | 1998 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 一般,3-8周 |
||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||
投稿链接 | http://ees.elsevier.com/jval | ||||||||||||||||||||
投稿官网 | http://www.valueinhealthjournal.com/ | ||||||||||||||||||||
h-index | 87 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1098-3015%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence Author: Zhihao Yang, Zeyun Feng, Jan Busschbach, Elly Stolk, Nan Luo Journal: VALUE IN HEALTH, 2019, Vol., , DOI:10.1016/j.jval.2018.12.008 DOI |
2. | Physical Activity and Risk of Breast Cancer: A Meta-Analysis of 38 Cohort Studies in 45 Study Reports Author: Xuyu Chen, Qiru Wang, Yanan Zhang, Qian Xie, Xiaodong Tan Journal: VALUE IN HEALTH, 2018, Vol.22, 104-128, DOI:10.1016/j.jval.2018.06.020 DOI |
3. | Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure: A Network Meta-Analysis Author: Wen-Qin Guo, Lang Li, Qiang Su, Wei-Ran Dai, Zi-Liang Ye Journal: VALUE IN HEALTH, 2017, Vol.20, 1427-1430, DOI:10.1016/j.jval.2017.04.010 DOI |
4. | Estimating an EQ-5D-5L Value Set for China Author: Nan Luo, Gordon Liu, Minghui Li, Haijing Guan, Xuejing Jin, Kim Rand-Hendriksen Journal: VALUE IN HEALTH, 2017, Vol.20, 662-669, DOI:10.1016/j.jval.2016.11.016 DOI |
5. | The Impact of China’s National Essential Medicine Policy and Its Implications for Urban Outpatients: A Multivariate Difference-in-Differences Study Author: Liman Ding, Jing Wu Journal: VALUE IN HEALTH, 2017, Vol.20, 412-419, DOI:10.1016/j.jval.2016.10.018 DOI |
6. | Economic Impacts of the Generic Drug User Fee Act Fee Structure Author: Ke Dong, Garth Boehm, Qiang Zheng Journal: VALUE IN HEALTH, 2017, Vol.20, 792-798, DOI:10.1016/j.jval.2016.05.003 DOI |
7. | Measuring High-Risk Patients’ Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction: A Discrete Choice Experiment Author: Di Dong, Semra Ozdemir, Yong Mong Bee, Sue-Anne Toh, Marcel Bilger, Eric Finkelstein Journal: VALUE IN HEALTH, 2016, Vol.19, 767-775, DOI:10.1016/j.jval.2016.03.1837 DOI |
8. | Importance of Economic Evaluation in Health Care: An Indian Perspective Author: amit.d Journal: VALUE IN HEALTH, 2016. |
9. | Importance of Economic Evaluation in Health Care: An Indian Perspective Author: amit.d Journal: VALUE IN HEALTH, 2016. |
10. | Drug reimbursement decision-making in Thailand, China, and South Korea. Author: Ngorsuraches S, Meng W, Kim BY, Kulsomboon V. Journal: Value Health. 2012 Jan-Feb;15(1 Suppl):S120-5. doi: 10.1016/j.jval.2011.11.002. PubMed |
|
|